Dr. Loven is Partner at Nextech, a leading, global investment firm that focuses on early, private-stage cancer companies. A scientific entrepreneur and biotech venture capitalist, Dr. Loven has extensive experience in creating, launching, and building early stage therapeutic companies in the US and most recently led the $57M launch of Relay Therapeutics from Third Rock Ventures, joining the company full time to lead corporate strategy, business development, and operations. Prior to Relay, Dr. Loven was a Scientific Co-Founder of Syros Pharmaceuticals (NASDAQ: SYRS) which was founded on his co-discoveries in gene regulation and was involved from its inception to advancing the first clinical candidate, growing the company to 30+ employees through to the initial public offering in July 2016. Jakob holds a BA in Biomedical Sciences from the Anglia Ruskin University of Cambridge, earned his Ph.D. in Medical Sciences from Karolinska Institutet, and conducted his postdoctoral fellowship at the Whitehead Institute for Biomedical Research.
Kronos Bio, Inc.
1300 So. El Camino Real
Suite 300
San Mateo, CA 94402
+1 (650) 781-5200
Kronos Bio, Inc.
301 Binney Street
2nd Floor East
Cambridge, MA 02142
© 2020 All rights reserved